Related Experiment Video
Updated: Feb 21, 2026
08:31
Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
736
Future perspectives for acute promyelocytic leukemia therapy
1H pital Saint-Louis, Laboratoire de Biologie Cellulaire Hématopoiétique, Paris, France.
Seminars in Hematology
|February 15, 2001
Summary
Acute promyelocytic leukemia (APL) therapy advances by targeting leukemic cells. Future APL treatments focus on cell characteristics and molecular markers for a potential cure.
Area of Science:
- Hematology
- Oncology
- Molecular Biology
Background:
- Acute promyelocytic leukemia (APL) was the first leukemia demonstrating targeted therapy effectiveness.
- Retinoic acid sensitivity identified specific APL leukemic clones responding in vivo.
Purpose of the Study:
- To explore future therapeutic strategies for APL.
- To identify key targets for APL treatment based on cellular characteristics and molecular markers.
Main Methods:
- Review of existing literature on APL targeted therapy.
- Analysis of recent advances in cellular therapy and cell differentiation concepts.
Main Results:
- Retinoic acid sensitivity is a key factor in APL treatment response.
- Targeting APL cell-specific characteristics (differentiation, cell cycle, survival) is crucial.
Conclusions:
- Future APL therapy should focus on molecular markers and cell-specific targets.
- Integrating cellular therapy and cell differentiation advances may lead to an APL cure.
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
01:22Bone Marrow Sampling and Transplants
1.7K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
1.7K
02:56Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
01:15Differentiation of Common Myeloid Progenitor Cells
4.1K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
4.1K